Cart
sales@molnova.com
c-Kit-IN-1
CAS No. 1225278-16-9
c-Kit-IN-1( —— )
Catalog No. M17203 CAS No. 1225278-16-9
DCC-2618 is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 80 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 288 | In Stock |
|
| 50MG | 514 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 500MG | 1521 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namec-Kit-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionDCC-2618 is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
-
DescriptionDCC-2618 is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).(In Vitro):c-Kit-IN-1 is a c-Kit and c-Met inhibitor extracted from patent 2010051373A1, compound example 45, has an IC50 of <200 nM. c-Kit-IN-1 also inhibits KDR, PDGFR α and β with IC50s of <2 μM, <10 μM and <10 μM, respectively.
-
In Vitroc-Kit-IN-1 is a c-Kit and c-Met inhibitor extracted from patent 2010051373A1, compound example 45, has an IC50 of <200 nM. c-Kit-IN-1 also inhibits KDR, PDGFR α and β with IC50s of <2 μM, <10 μM and <10 μM, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetCaMK
-
Recptorc-Kit| c-Met
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1225278-16-9
-
Formula Weight489.47
-
Molecular FormulaC26H21F2N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL. 204.30 mM
-
SMILESCn1cc(cn1)c1nccc(c1)Oc1c(cc(c(c1)F)NC(=O)C1(CC1)C(=O)Nc1ccccc1)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Daniel L. Flynn, et al. Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities. WO 2010051373 A1
molnova catalog
related products
-
W-7 HCl
W-7 HCl, a calmodulin antagonist, inhibits Ca2+-calmodulin-dependent myosin light chain kinase and phosphodiesterase, W-7 hydrochloride induces apoptosis and has antitumor activity
-
Calmodulin-Dependent...
Calmodulin-Dependent Protein Kinase II (290-309) is a potent CaMK antagonist with an IC50 of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.
-
Calmidazolium chlori...
Calmidazolium chloride is a calmodulin (CaMK) antagonist (Kd = 3 nM), antagonizing CaM-dependent phosphodiesterase(IC50 = 0.15 μM) and calmodulin-induced activation of erythrocyte Ca2+-transporting ATPase(IC50 = 0.35 μM).
